title: Studies on homocysteine demonstrating its significance as a possible tool for differential diagnosis in occlusive vascular disease.
abstract: Homocysteine (Hcy) is a non-protein forming amino-acid, whose metabolism is at the intersection of two metabolic pathways: remethylation and transsulfuration which are dependent on the vitamins folic acid, B(12) and B(6), and the enzymes methylenetetrahydrofolate reductase and cystathionine-β-synthetase. A deficiency of any of these vitamins or enzymes results in hyperhomocysteinemia. This causes oxidative and other damage to blood vessels, thus affecting various organ systems of the body. As part of our ongoing research on cardiovascular risk factors, we have studied the Hcy levels in the plasma of normal controls and those suffering from vascular diseases. It was observed that Hcy is significantly higher in patients of vascular diseases (21.59±1.28 μmol/L, mean±SEM), as compared to normal controls (11.33±0.18 μmol/L). This significance, was more pronounced in cases of venous thrombosis (26.77±2.43 μmol/L) as opposed to cases of arterial block (17.27±0.84 μmol/L). This signifies that Hcy estimation would be beneficial in obtaining a differential diagnosis in addition to being a modifiable vascular risk factor.
authors.affiliation: Department of Biochemistry, Sir Ganga Ram Hospital, 110060 New Delhi.
authors.forename: Seema
authors.initials: S
authors.lastname: Bhargava
authors.forename: R
authors.initials: R
authors.lastname: Parakh
authors.forename: L M
authors.initials: LM
authors.lastname: Srivastava
keywords: Hyperhomocysteinemia; Vascular Disease